Primary splenic angiosarcoma: case report and literature review

Luís Fernando Venegas,Paula Ratfin Pohlmann,Alexsandra Lima Balbinot,Eduardo Schuck,Carla T. M. de Oliveira,Klaus J. Frank,Carlos F. Dillemburg,Mário S. B. da Costa,Luis Fernando R. Rivero,Antonio C. K. Pütten
DOI: https://doi.org/10.32635/2176-9745.rbc.1998v44n1.2800
2022-09-27
Revista Brasileira de Cancerologia
Abstract:This paper describes a case of an aggressive primary splenic angiosarcoma in a 29-year-old man and makes a review of its clinicai findings, pathologic reports, treatment and prognosis. Angiosarcomas comprise less than 1% of soft tissue sarcomas, and only a small percentage of these tumors arise in the spleen. These tumors usually represent a diagnostic challenge for the pathologist in view of its variegated histology, and the development of new immu-nohistochemical markers for vascular tumors like CD31 (platelet-endothelial cell adhesion molecule) helps to rule out other diagnoses. There is no standard chemotherapy treatment for angiosarcomas, and the prognosis of splenic angiosarcoma is particularly poor.
What problem does this paper attempt to address?